These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37804962)

  • 1. Weighted hypergraph learning and adaptive inductive matrix completion for SARS-CoV-2 drug repositioning.
    Ma Y; Zhong J; Zhu N
    Methods; 2023 Nov; 219():102-110. PubMed ID: 37804962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
    Su X; Hu L; You Z; Hu P; Wang L; Zhao B
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized matrix factorization based on weighted hypergraph learning for microbe-drug association prediction.
    Ma Y; Liu Q
    Comput Biol Med; 2022 Jun; 145():105503. PubMed ID: 35427986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAveRUNNER: an R-based tool for drug repurposing.
    Fiscon G; Paci P
    BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ensemble Matrix Completion Model for Predicting Potential Drugs Against SARS-CoV-2.
    Li W; Wang S; Xu J
    Front Microbiol; 2021; 12():694534. PubMed ID: 34367094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
    Goel B; Bhardwaj N; Tripathi N; Jain SK
    Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
    Yao Y; Zhang Y; Li Z; Chen Z; Wang X; Li Z; Yu L; Cheng X; Li W; Jiang WJ; Wu HJ; Feng Z; Sun J; Fei T
    Biochem Biophys Res Commun; 2023 Oct; 675():113-121. PubMed ID: 37467664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives for repurposing drugs for the coronavirus disease 2019.
    Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
    Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
    Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19.
    Tang X; Cai L; Meng Y; Xu J; Lu C; Yang J
    Front Immunol; 2020; 11():603615. PubMed ID: 33584672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.
    Barsi S; Papp H; Valdeolivas A; Tóth DJ; Kuczmog A; Madai M; Hunyady L; Várnai P; Saez-Rodriguez J; Jakab F; Szalai B
    PLoS Comput Biol; 2022 Apr; 18(4):e1010021. PubMed ID: 35404937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repositioning based on multi-view learning with matrix completion.
    Yan Y; Yang M; Zhao H; Duan G; Peng X; Wang J
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35289352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
    Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
    Mishra J; Prasun C; Sahoo PK; Nair MS
    Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new drug indications for COVID-19: A drug repurposing approach.
    Kumari P; Pradhan B; Koromina M; Patrinos GP; Steen KV
    PLoS One; 2022; 17(5):e0267095. PubMed ID: 35609015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.